Gross Margin % is calculated as gross profit divided by its revenue. Sibannac's Gross Profit for the
three
months ended in Feb. 2017 was $-0.00 Mil. Sibannac's Revenue for the
three
months ended in Feb. 2017 was $0.00 Mil. Therefore, Sibannac's Gross Margin % for the quarter that ended in Feb. 2017 was 0.00%.
The historical rank and industry rank for Sibannac's Gross Margin % or its related term are showing as below:
SNNC's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.54 * Ranked among companies with meaningful Gross Margin % only.
Sibannac had a gross margin of % for the quarter that ended in Feb. 2017 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Sibannac was 0.00% per year.
Sibannac (OTCPK:SNNC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sibannac had a gross margin of % for the quarter that ended in Feb. 2017 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sibannac Gross Margin % Related Terms
Sibannac Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sibannac's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SNNC vs LIVC, OTTV, FPTA: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sibannac's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sibannac Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sibannac's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sibannac's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sibannac (SNNC) has a Gross Margin % of 0.00% as of Feb. 2017. Gross margin is the ratio of total gross profit to net sales. View historical data on Sibannac and its competitors.
Is Sibannac's Gross Margin % too high?
Sibannac's current Gross Margin % is 0.00%.
How does Sibannac's Gross Margin % compare to LIVC and OTTV?
Sibannac's Gross Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Gross Margin % is 48.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sibannac and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sibannac's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sibannac stock overvalued right now?
Sibannac (SNNC) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sibannac (SNNC), the current Gross Margin % is 0.00% as of Feb. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sibannac Inc is a cannabis research and development company with a portfolio of hemp beauty and body products, hemp animal care products, hemp clothing and accessories, and hemp paper and plastic products. Its products include oils, creams, lotions, treats, foods, shirts, pants, and dresses, and it also develops new hemp products. The group manufactures its products in Geneva, New York, and Charlotte, North Carolina. Its subsidiary business units include NOHO, Cherryology, and RaD8 Life, and associated brands include NOHO, Higher Times, Starwalker Cafe, The Meru Sky, consumer brands such as Converse, Titleist, FootJoy, Coca-Cola, Pepperidge Farm, and practitioner and nutraceutical brands including ChiroTouch, Emerson Ecologics, Reserveage, Gaia Herbs, Organic India, and NeoCell.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNNC has been successfully added to your 